AI Article Synopsis
- * Nanosystems are being developed for targeted drug delivery that can modulate adenosine signaling and improve tumor immunotherapy effectiveness by targeting adenosine-hydrolyzing proteins and receptors.
- * Experts believe that utilizing adenosine in cancer immunotherapy and advanced nano-drug delivery systems will enhance targeted therapy outcomes in the near future.
Article Abstract
Introduction: Adenosine (ADO) is a naturally occurring nucleoside primarily synthesized through the hydrolysis of extracellular adenosine triphosphate. Within the tumor microenvironment, ADO levels substantially increase, resulting in suppressed immune responses.
Areas Covered: Nanosystems offer a promising approach for precise drug delivery to tumor lesions. In this review, we provide an overview of the current research progress in the development of nanosystems that modulate adenosine signaling for tumor immunotherapy. These nanosystems are designed to target adenosine-hydrolyzing proteins, increase adenosine decomposition, and antagonize adenosine receptors.
Expert Opinion: Based on the literature review, adenosine has great potential in tumor immunotherapy, and nano-drug delivery system has great application prospects in targeted cancer therapy in the near future due to its superior characteristics.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/17425247.2024.2417687 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!